Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 40 | 2025 | 5197 | 3.890 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 5 | 2020 | 178 | 1.810 |
Why?
|
Bone Marrow | 9 | 2022 | 2921 | 1.170 |
Why?
|
Proteasome Endopeptidase Complex | 5 | 2022 | 1314 | 0.820 |
Why?
|
Immunoglobulin Light Chains | 4 | 2024 | 290 | 0.800 |
Why?
|
Aspartic Acid Proteases | 1 | 2022 | 9 | 0.790 |
Why?
|
NF-E2-Related Factor 1 | 1 | 2022 | 21 | 0.790 |
Why?
|
Ethylene Glycols | 5 | 2024 | 196 | 0.750 |
Why?
|
Thrombotic Microangiopathies | 1 | 2023 | 125 | 0.740 |
Why?
|
Plasma Cells | 3 | 2020 | 591 | 0.680 |
Why?
|
Hypotension, Orthostatic | 1 | 2022 | 257 | 0.630 |
Why?
|
Paraproteinemias | 2 | 2019 | 252 | 0.610 |
Why?
|
Immunoproliferative Small Intestinal Disease | 1 | 2018 | 4 | 0.600 |
Why?
|
Aniline Compounds | 5 | 2024 | 1075 | 0.560 |
Why?
|
Amyloid | 3 | 2023 | 853 | 0.550 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5753 | 0.510 |
Why?
|
Tumor Microenvironment | 6 | 2022 | 3946 | 0.490 |
Why?
|
Receptors, Immunologic | 2 | 2021 | 1415 | 0.490 |
Why?
|
Histone Deacetylases | 1 | 2019 | 708 | 0.470 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2014 | 84 | 0.450 |
Why?
|
Heavy Chain Disease | 1 | 2014 | 19 | 0.450 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2025 | 11868 | 0.400 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2024 | 5337 | 0.400 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2729 | 0.390 |
Why?
|
Hydroxamic Acids | 1 | 2014 | 483 | 0.380 |
Why?
|
Imidazoles | 2 | 2014 | 1162 | 0.380 |
Why?
|
Transplantation, Autologous | 3 | 2022 | 2120 | 0.360 |
Why?
|
Thalidomide | 4 | 2024 | 886 | 0.350 |
Why?
|
Amyloidosis | 3 | 2023 | 885 | 0.330 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2009 | 186 | 0.320 |
Why?
|
Quinolines | 1 | 2014 | 769 | 0.310 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4392 | 0.300 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1663 | 0.300 |
Why?
|
Dexamethasone | 6 | 2025 | 1963 | 0.300 |
Why?
|
Cardiomyopathies | 5 | 2024 | 2067 | 0.300 |
Why?
|
Fluorine Radioisotopes | 2 | 2020 | 397 | 0.270 |
Why?
|
Indoles | 1 | 2014 | 1839 | 0.260 |
Why?
|
Mutation | 3 | 2024 | 30198 | 0.240 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1434 | 0.230 |
Why?
|
Radiopharmaceuticals | 3 | 2024 | 2699 | 0.230 |
Why?
|
Humans | 57 | 2025 | 765968 | 0.230 |
Why?
|
Boron Compounds | 1 | 2025 | 196 | 0.210 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 230 | 0.210 |
Why?
|
Complement Pathway, Alternative | 1 | 2023 | 106 | 0.200 |
Why?
|
Signal Transduction | 8 | 2021 | 23601 | 0.200 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4528 | 0.200 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15398 | 0.190 |
Why?
|
Glycine | 1 | 2025 | 672 | 0.180 |
Why?
|
Myeloma Proteins | 1 | 2021 | 71 | 0.180 |
Why?
|
Myocardium | 3 | 2024 | 4760 | 0.180 |
Why?
|
Antibodies, Bispecific | 1 | 2023 | 203 | 0.180 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2021 | 37 | 0.180 |
Why?
|
Prognosis | 7 | 2024 | 29922 | 0.180 |
Why?
|
Bone Marrow Cells | 3 | 2021 | 2412 | 0.180 |
Why?
|
Plasmacytoma | 1 | 2021 | 174 | 0.170 |
Why?
|
Apoptosis | 6 | 2023 | 9514 | 0.170 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2024 | 1094 | 0.170 |
Why?
|
Disease Progression | 5 | 2025 | 13632 | 0.160 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 13648 | 0.160 |
Why?
|
14-3-3 Proteins | 1 | 2020 | 221 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 1 | 2024 | 1066 | 0.160 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 507 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2021 | 462 | 0.160 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2024 | 1736 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2024 | 1151 | 0.160 |
Why?
|
Endothelial Cells | 3 | 2021 | 3584 | 0.150 |
Why?
|
Campylobacter jejuni | 1 | 2018 | 24 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2024 | 645 | 0.150 |
Why?
|
Campylobacter Infections | 1 | 2018 | 32 | 0.150 |
Why?
|
Molecular Targeted Therapy | 4 | 2024 | 2822 | 0.140 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2900 | 0.140 |
Why?
|
Proton Pump Inhibitors | 1 | 2022 | 553 | 0.140 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 1009 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 899 | 0.130 |
Why?
|
Protein Biosynthesis | 2 | 2012 | 2086 | 0.120 |
Why?
|
Peptide Fragments | 2 | 2024 | 5125 | 0.120 |
Why?
|
Oligopeptides | 1 | 2020 | 1192 | 0.120 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3928 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9373 | 0.120 |
Why?
|
Boronic Acids | 3 | 2014 | 916 | 0.120 |
Why?
|
Exosomes | 1 | 2019 | 421 | 0.120 |
Why?
|
Immunologic Factors | 2 | 2014 | 1587 | 0.110 |
Why?
|
Diphosphonates | 2 | 2021 | 625 | 0.110 |
Why?
|
Osteogenesis | 1 | 2021 | 1282 | 0.110 |
Why?
|
Animals | 15 | 2024 | 168764 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1761 | 0.110 |
Why?
|
Mice | 11 | 2024 | 81819 | 0.110 |
Why?
|
Pyrazines | 3 | 2014 | 1204 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2033 | 0.100 |
Why?
|
Ubiquitin | 2 | 2008 | 839 | 0.100 |
Why?
|
Immunophenotyping | 2 | 2014 | 1866 | 0.090 |
Why?
|
Early Diagnosis | 2 | 2020 | 1187 | 0.090 |
Why?
|
Aged | 13 | 2025 | 171117 | 0.090 |
Why?
|
Risk Factors | 5 | 2024 | 74840 | 0.090 |
Why?
|
Cell Proliferation | 4 | 2023 | 10429 | 0.090 |
Why?
|
Protein Folding | 1 | 2014 | 869 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2023 | 8611 | 0.090 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 239 | 0.090 |
Why?
|
Back Pain | 1 | 2014 | 544 | 0.090 |
Why?
|
Middle Aged | 13 | 2025 | 223009 | 0.090 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6113 | 0.080 |
Why?
|
Minnesota | 1 | 2010 | 336 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2016 | 976 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3222 | 0.080 |
Why?
|
Leupeptins | 1 | 2009 | 112 | 0.080 |
Why?
|
Bone Remodeling | 1 | 2012 | 577 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2567 | 0.080 |
Why?
|
Translocation, Genetic | 1 | 2014 | 1394 | 0.080 |
Why?
|
Observation | 1 | 2010 | 309 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3596 | 0.070 |
Why?
|
Azepines | 1 | 2010 | 327 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2024 | 17075 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1668 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2025 | 59489 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2012 | 11641 | 0.070 |
Why?
|
Fatigue | 1 | 2014 | 1549 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3785 | 0.070 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 791 | 0.070 |
Why?
|
Biopsy | 2 | 2019 | 6763 | 0.070 |
Why?
|
Male | 14 | 2025 | 363698 | 0.070 |
Why?
|
Protease Inhibitors | 2 | 2009 | 746 | 0.070 |
Why?
|
Heart Failure | 3 | 2024 | 11840 | 0.060 |
Why?
|
Female | 14 | 2025 | 396112 | 0.060 |
Why?
|
Mice, SCID | 3 | 2021 | 2630 | 0.060 |
Why?
|
HeLa Cells | 2 | 2009 | 3067 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2844 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8041 | 0.060 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.060 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.060 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 82 | 0.060 |
Why?
|
Kidney | 1 | 2019 | 7066 | 0.050 |
Why?
|
Proteomics | 1 | 2017 | 3910 | 0.050 |
Why?
|
Calreticulin | 1 | 2024 | 111 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8529 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2009 | 3586 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1132 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13462 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2023 | 153 | 0.050 |
Why?
|
Salvage Therapy | 2 | 2021 | 1272 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2056 | 0.050 |
Why?
|
Cell Communication | 1 | 2009 | 1660 | 0.050 |
Why?
|
Heart Ventricles | 2 | 2024 | 3832 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2021 | 56 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2009 | 1402 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5929 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 577 | 0.050 |
Why?
|
Drug Administration Routes | 1 | 2021 | 152 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3615 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6610 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2025 | 65188 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 54802 | 0.040 |
Why?
|
Heart Transplantation | 2 | 2024 | 3310 | 0.040 |
Why?
|
Time Factors | 5 | 2024 | 40065 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11206 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9249 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7478 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 242 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 612 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2022 | 81514 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 634 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2009 | 2747 | 0.040 |
Why?
|
Parotid Gland | 1 | 2019 | 177 | 0.040 |
Why?
|
Pyrimidines | 1 | 2010 | 3047 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 990 | 0.030 |
Why?
|
Autophagy | 1 | 2024 | 1351 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 741 | 0.030 |
Why?
|
Treatment Failure | 1 | 2022 | 2652 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2009 | 4778 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2266 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1892 | 0.030 |
Why?
|
Child | 1 | 2023 | 80564 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15880 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5696 | 0.030 |
Why?
|
DNA Damage | 1 | 2023 | 2457 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2411 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4850 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7425 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2485 | 0.030 |
Why?
|
Osteoclasts | 1 | 2016 | 713 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5045 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2015 | 962 | 0.020 |
Why?
|
Transplantation, Heterologous | 2 | 2010 | 2394 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2980 | 0.020 |
Why?
|
Osteoblasts | 1 | 2016 | 1143 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8733 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5329 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 330 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2009 | 705 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14751 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2476 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 639 | 0.020 |
Why?
|
Adult | 3 | 2025 | 223044 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4772 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2015 | 3160 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22223 | 0.020 |
Why?
|
Chemotaxis | 1 | 2009 | 596 | 0.020 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2006 | 62 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2014 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 583 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1336 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1167 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 209 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36532 | 0.020 |
Why?
|
Software | 1 | 2019 | 4462 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 2006 | 283 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5020 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7851 | 0.010 |
Why?
|
Doxorubicin | 1 | 2010 | 2230 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24282 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8923 | 0.010 |
Why?
|
Cell Cycle | 1 | 2010 | 2920 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5881 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3608 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10033 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2006 | 1528 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 2060 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12768 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2796 | 0.010 |
Why?
|
Spleen | 1 | 2006 | 2296 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5747 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 2216 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39193 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7421 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9550 | 0.010 |
Why?
|
United States | 1 | 2020 | 72903 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10261 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2006 | 5783 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2006 | 9601 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22332 | 0.000 |
Why?
|
Transcription Factors | 1 | 2006 | 12131 | 0.000 |
Why?
|